Targeting mitochondrial biogenesis and function in Parkinson’s disease
Please note now WEDNESDAY July 19th
Dr. Deleidi group’s research aims to identify key molecular pathways in the pathogenesis of sporadic and familial Parkinson’s using human neurons derived from induced pluripotent stem cells (iPSCs).

Michela Deleidi is studying human ageing processes and age-related neurological disorders with a particular focus on Parkinson’s. She wants to employ stem cells from people affected by the condition and investigate how the immune system and mitochondria, the powerhouses of our cells, interact with each other. This should give more information about how inflammation in Parkinson’s plays a role in the development of the condition.
www.dzne.de/standorte/tuebingen/forschergruppen/deleidi.html
Date: 19 July 2017, 16:00 (Wednesday, 13th week, Trinity 2017)
Venue: Sherrington Building, off Parks Road OX1 3PT
Venue Details: Sherrington Library, please note doors are locked at 4pm
Speaker: Michela Deleidi (DZNE)
Organising department: Department of Physiology, Anatomy and Genetics (DPAG)
Organiser: Melanie Witt (University of Oxford, Department of Earth Sciences, Department of Physiology Anatomy and Genetics)
Organiser contact email address: opdc.administrator@dpag.ox.ac.uk
Part of: OPDC Seminar Series (DPAG)
Topics:
Booking required?: Not required
Audience: Members of the University only
Editor: Melanie Witt